Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@jax.org
Drug Name | GNOS-PV02 |
Trade Name | |
Synonyms | GNOS-PV2|GNOS PV02|GNOS PV2\GNOSPV02 |
Drug Descriptions |
GNOS-PV02 is a personalized neoantigen cancer vaccine comprising a DNA plasmid encoding upto 40 patient-derived neoantigens, which may induce antitumor immune response and inhibit tumor growth (PMID: 38584166). |
DrugClasses | |
CAS Registry Number | NA |
NCIT ID | NA |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
GNOS-PV02 | GNOS-PV02 | 0 | 0 |
GNOS-PV02 + IL-12 gene + Pembrolizumab | GNOS-PV02 IL-12 gene Pembrolizumab | 0 | 0 |